Cargando…
Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
Robust patient-derived platforms that recapitulate the cellular and molecular fingerprints of glioblastoma are crucial for developing effective therapies. Here, we describe a chemically defined protocol for 3D culture and propagation of glioblastoma in 3D gliospheres, patient-derived organoids (PDOs...
Autores principales: | Gamboa, Christian Moya, Jara, Kelly, Pamarthy, Sahithi, Liu, Liqiong, Aiken, Robert, Xiong, Zhenggang, Danish, Shabbar, Sabaawy, Hatem E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903462/ https://www.ncbi.nlm.nih.gov/pubmed/33665625 http://dx.doi.org/10.1016/j.xpro.2021.100345 |
Ejemplares similares
-
Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine
por: Pamarthy, Sahithi, et al.
Publicado: (2021) -
Rapid Processing and Drug Evaluation in Glioblastoma Patient-Derived Organoid Models with 4D Bioprinted Arrays
por: Chadwick, Michelle, et al.
Publicado: (2020) -
Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy
por: Patrizii, Michele, et al.
Publicado: (2018) -
Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors
por: Oudin, Anaïs, et al.
Publicado: (2021) -
Generation of orthotopic patient-derived xenograft models for pancreatic cancer using tumor slices
por: Curiel-Garcia, Alvaro, et al.
Publicado: (2022)